It is included on the 2026 WADA Monitoring Program, which tracks markers of semaglutide and tirzepatide use across sports without imposing sanctions, allowing WADA to identify patterns of potential misuse that may inform future Prohibited List decisions
(A) Hematoxylin & eosin staining (x20) found a well-circumscribed, non-inflammatory dermal mass with atypical melanocytes, and no epidermal connection
Industry research standard is 99%+
Managing that timeline honestly, up front, is one of the most important skills a clinician can bring to this conversation
That way, youre not endlessly scrollingyoure seeing the conversations clinicians and researchers are actively having about both benefits and risks
Colorimetric measures did not show statistical difference between both sides